PestleMedicine Explained

Denosumab

Prolia contains denosumab, a protein (monoclonal antibody) that treats bone loss and osteoporosis by making bone stronger and less likely to break. It is used for osteoporosis in women after the menopause and in men at increased risk of fracture, for bone loss caused by hormone reduction in prostate cancer treatment, and for bone loss caused by long-term glucocorticoid treatment.

Active ingredient: denosumab

Official leaflet

Key facts

  1. The usual dose is one 60 mg injection under the skin once every 6 months.
  2. You should also take calcium and vitamin D supplements during treatment, and your blood calcium levels will be checked.
  3. Tell your doctor immediately if you have symptoms of low blood calcium, a skin infection, or mouth, tooth or jaw problems.
  4. Keep up good oral hygiene and routine dental check-ups, and tell your dentist you are being treated with Prolia.
  5. Do not stop treatment without contacting your doctor, and do not use Prolia in anyone under 18.

Who should not take denosumab

The leaflet says not to take it if any of these apply to you.

  • if you have low calcium levels in the blood (hypocalcaemia)
  • if you are allergic to denosumab or any of the other ingredients of this medicine

Check with a doctor or pharmacist first

Tell them before you take it if any of these apply to you.

  • skin infection with a swollen, red, hot and tender area of skin, most commonly in the lower leg (cellulitis), possibly with fever: tell your doctor immediately
  • low blood calcium symptoms: muscle spasms, twitches or cramps, numbness or tingling in fingers, toes or around the mouth, seizures, confusion or loss of consciousness: tell your doctor immediately
  • severe kidney problems, kidney failure or needing dialysis, which may increase the risk of low blood calcium
  • taking glucocorticoids (such as prednisolone or dexamethasone), which may increase the risk of low blood calcium if you do not take calcium supplements
  • problems with your mouth or teeth such as poor dental health, gum disease or a planned tooth extraction
  • not receiving routine dental care or not having had a dental check-up for a long time
Show 7 moreShow fewer
  • being a smoker
  • previous treatment with a bisphosphonate
  • taking corticosteroids (such as prednisolone or dexamethasone)
  • having cancer
  • new or unusual pain in your hip, groin or thigh (unusual thigh bone fractures)
  • known allergies, because the polysorbate in Prolia may cause allergic reactions
  • not for children and adolescents under 18 years of age

How to take denosumab

  • The recommended dose is one 60 mg pre-filled syringe once every 6 months, as a single injection under the skin (subcutaneous).
  • The best places to inject are the top of the thighs and the abdomen; a carer can also use the outer upper arm. Do not shake.
  • Take calcium and vitamin D supplements as your doctor advises.
  • If a dose is missed, inject as soon as possible, then schedule injections every 6 months from that date.
  • Do not stop treatment without contacting your doctor.

Side effects

Get medical help straight away

The leaflet says to get help urgently, or to stop the medicine and speak to a doctor, if you notice any of these. In an emergency call 999.

  • skin infections, predominantly cellulitis: swollen, red area of skin, most commonly in the lower leg, hot and tender, possibly with fever (uncommon)
  • osteonecrosis (bone damage) of the jaw: pain in the mouth or jaw, swelling or non-healing sores, discharge, numbness or heaviness in the jaw, or loosening of a tooth (rare)
  • low calcium levels in the blood (hypocalcaemia), which can be severe, lead to hospitalisation and may be life-threatening: muscle spasms, twitches or cramps, numbness or tingling, seizures, confusion or loss of consciousness (rare)
  • unusual fractures of the thigh bone: new or unusual pain in the hip, groin or thigh (rare)
  • allergic reactions: swelling of the face, lips, tongue, throat or other parts of the body, rash, itching or hives, wheezing or difficulty breathing (rare)

How common each side effect is

Grouped the way the leaflet groups them. Most people get none, or only a few. Each figure is the most that are affected, so "up to 1 in 10" can mean far fewer.

Very common

More than 1 in 10 people

  • bone, joint and/or muscle pain which is sometimes severe
  • arm or leg pain (pain in extremity)

Common

Up to 1 in 10 people

  • painful urination
  • frequent urination
  • blood in the urine
  • inability to hold your urine
  • upper respiratory tract infection
  • pain, tingling or numbness that moves down your leg (sciatica)
  • constipation
  • abdominal discomfort
  • rash
  • skin condition with itching, redness and/or dryness (eczema)
Show 1 moreShow fewer
  • hair loss (alopecia)

Uncommon

Up to 1 in 100 people

  • skin infections (predominantly cellulitis)
  • fever, vomiting and abdominal pain or discomfort (diverticulitis)
  • ear infection
  • rash that may occur on the skin or sores in the mouth (lichenoid drug eruptions)
  • injection site reactions including pain around the site where the injection was given

Rare

Up to 1 in 1,000 people

  • pain in the mouth and/or jaw, swelling or non-healing of sores in the mouth or jaw, discharge, numbness or a feeling of heaviness in the jaw, or loosening of a tooth (osteonecrosis of the jaw)
  • low calcium levels in the blood (hypocalcaemia)
  • unusual fractures of the thigh bone
  • allergic reactions

Very rare

Up to 1 in 10,000 people

  • allergic reaction that can damage blood vessels mainly in the skin (hypersensitivity vasculitis)

Not known

The leaflet says how often is not known

  • ear pain, discharge from the ear and/or an ear infection (signs of bone damage in the ear)

Not stated

The leaflet gives no frequency

  • change in heart rhythm called QT prolongation seen on ECG (linked to low blood calcium)

If you get a side effect, you can report it to the regulator through the Yellow Card scheme.

Pregnancy and breastfeeding

Prolia has not been tested in pregnant women and is not recommended in pregnancy; women who could become pregnant should use effective contraception during treatment and for at least 5 months after stopping. It is not known whether Prolia passes into breast milk, so tell your doctor if you are breast-feeding or plan to, and they will help you decide whether to stop breast-feeding or stop Prolia.

Taking it with other medicines

The leaflet says to tell your doctor or pharmacist if you take any of these. This list is not checked against the medicines you take.

  • any other medicines you are taking, have recently taken or might take
  • another medicine containing denosumab (do not use together with Prolia)
  • glucocorticoids or corticosteroids (such as prednisolone or dexamethasone)
  • bisphosphonates (if previously treated)

Where this comes from

Everything on this page is taken from one official document: the patient information leaflet that the UK medicines regulator (MHRA) approved for this product. Pestle reorganises it and puts it in plainer words. It adds nothing from anywhere else and does not rate medicines.

Product
Prolia 60 mg Solution For Injection In Pre-Filled Syringe
Product licence
PLPI394670743
Leaflet dated
Checked against the leaflet
Automated check
25 of 25 side effects matched to the wording of the leaflet

Other makers of denosumab publish their own leaflets, which can differ slightly. Always read the leaflet that came with your medicine.

Read the official leaflet Original on the MHRA site How we make these pages

The same facts for software and AI agents: JSON · Markdown.